NewTimeSpace News:The Stock Exchange of Hong Kong Limited announced that with effect from 9:00 a.m. on February 16, 2026, the listing of Greater Bay Area Dynamic Growth Holding Limited (01189.HK) will be cancelled pursuant to Rule 6.01A(1) of the Listing Rules. The company’s shares have been suspended from trading since April 2, 2024, and it failed to comply with the resumption guidance by October 1, 2025.
NewTimeSpace News, on February 12, the manager of Singapore-listed Elite UK REIT announced that it has obtained planning approval from the Planning Committee to develop a large-scale data centre on approximately 37 acres of freehold land at Peel Park, Blackpool, UK.
February 11, 2026, TAI PING CARPET(00146.HK) released its Interim Report for the period ended June 30, 2026, Total Revenue stood at HKD 309.48 million, increased by 0.36% YoY
NewTimeSpace News, Singapore-registered SPINDEX INDUSTRIES LIMITED announced on February 11 that it has confirmed the payment of the acquisition consideration to all shareholders on the same day. Meanwhile, the company declared that it will be delisted from the official list of the Singapore Exchange (SGX) on February 13, 2026.
NewTimeSpace News, according to the announcement disclosed on the Singapore Exchange on February 10, Centurion Asset Management Pte. Ltd., the manager of Centurion Accommodation REIT, has obtained provisional approval for the Westlite Ubi Project. It plans to construct a new 6-storey building and renovate the existing 8-storey building. Upon completion, the project will add 540 beds with an estimated cost of approximately S$13.9 million.
NewTimeSpace News,Leighton Asia, a subsidiary of Australia’s CIMIC Group, announced on February 9 that it has successfully won the main works contract for a data centre project in Johor Bahru, Malaysia. The project is part of a greenfield campus development and is scheduled for completion in 2028.
NewTimeSpace News: Nanjing Leads Biolabs Co., Ltd. (09887.HK) announced that the first patient dosing has been completed in the Phase Ib/II clinical trial of its core product Velixin™ (LBL-024) for the treatment of relapsed or metastatic triple-negative breast cancer, marking new progress in the development of this drug for breast cancer indications.
Lockin Tech filed HKEX IPO.2024 vein lock leader(10.5%).Q1-Q3 revenue RMB774M,profit RMB32M.Baidu holds 18.43%.Proceeds for biometric R&D.
NewTimeSpace News: POP MART (09992.HK) has released a business update announcement, stating that the total global sales volume of products under all its IPs surpassed 400 million units in 2025. Among them, the core IP "THE MONSTERS" achieved annual global sales of over 100 million units, serving as a crucial sales pillar.
NewTimeSpace News, JIUYUAN GENE announced on February 9 that the Investigational New Drug (IND) application for JY54 Injection, a self-developed Class 1 chemical innovative drug, has been officially accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration. The drug is focused on weight management for obese or overweight populations and has demonstrated excellent preclinical data.
NewTimeSpace News: Peijia Medical Limited (09996.HK) announced on February 9, 2026 that the company has recently officially submitted the EU MDR CE mark registration application for its self-developed GeminiOne® Transcatheter Edge-to-Edge Repair System for the treatment of mitral regurgitation, marking progress in the product's global strategic layout. The registration application for the product in China has also been accepted, and it has obtained approval from the US FDA to initiate early clinical studies.
NewTimeSpace News: Butong Group Limited (06090.HK) announced that the trustee of its share incentive plan purchased a total of 50,000 existing shares on the market on February 6, 2026, with a total consideration of approximately HK$4.8087 million and an average price of approximately HK$96.17 per share.
On February 4, 2026, affected by the sell-off in software stocks triggered by overseas AI automation tools, global e-commerce SaaS leader JST (06687.HK) recorded its largest single-day decline since listing. As of the close on February 5, the stock JST has cumulatively fallen 28.10% since its October 2025 IPO. The market is questioning whether AI will shrink pricing margins for software and destabilize the traditional subscription model, leaving the software industry facing a severe "replacement crisis."
NewTimeSpace News: Luenthai Holdings Limited (00311.HK) issued a profit warning, expecting to record a profit attributable to owners of the company of approximately US$3.8 million to US$4.8 million for the year ended December 31, 2025. This marks a turnaround from a net loss of about US$34 million in the previous fiscal year.
NewTimeSpace News,HENLIUS announced in an announcement on February 5 that it has entered into a license agreement with Eisai, a listed Japanese pharmaceutical company, authorizing Eisai to develop, manufacture and commercialize Hansoh® (Serplulimab Injection) for the treatment of oncology indications in Japan.
NewTimeSpace News, JIHONG CO announced on February 5 that its controlling shareholder and actual controller, Ms. Zhuang Hao, has unpledged 8.6 million shares. These shares account for 12.93% of her total holdings and 1.91% of the company’s total share capital. The unpledging date is February 2, 2026, and the pledgee is China Galaxy Securities Co., Ltd.
